Comment from Mendizabal Marta
AnonymousSupportIndividual
Summary: An individual patient who uses compounded peptides for chronic pain and fatigue is requesting that specific peptides (BPC-157, TB500, Semax, KPV, and MOTS-C) be added to the 503A Bulk Drug Substances List. They argue that these substances are safe and effective when prescribed by doctors and should be accessible to patients with various health issues.
For almost 10 years I have personally struggled with joint pain, fatigue and brain fog that were unresponsive to conventional therapies. I have been fortunate enough to have learned about peptides and been prescribed several compounded options, including BPC-157, TB500, Semax, KPV and MOTS-C. I can honestly say that nothing has ever worked so well for my symptoms as these peptides have. Unfortunately, I recently lost access to all of these options, as I am being told that they are not allowed to be prescribed to Ohio residents. This is heartbreaking, as they have been so helpful for me. I certainly do not want to purchase them from research sources as some people do to continue receiving the benefits I have become accustomed to. Please consider allowing doctors to prescribe these wonderful peptides in situations where they feel they would be helpful. There are so many people struggling with various health issues who can benefit from safe, responsible peptide access with proper medical guidance. I sincerely hope that you will allow these few options to be added to the 503A list for the benefit of all, especially since they are overwhelmingly safer than most drugs being prescribed today. Thank you so much for taking the time to review my comment. God bless!